KNAW

Research

A double-blind, randomized, parallel group, placebo controlled, sequential...

Pagina-navigatie:


Update content


Title A double-blind, randomized, parallel group, placebo controlled, sequential dose escalation study of anti-MCP-1 therapy in patients with rheumatoid arthritis
Period 01 / 2003 - unknown
Status Completed
Research number OND1294007
Data Supplier Aangemeld door projectleider

Related organisations

Related people

Project leader Prof.dr. P.P. Tak

Classification

A34800 Drugs and pesticides
A73200 Second-line health care
D23210 Dermatology, venereology, rheumatology, orthopedics
D23340 Biopharmacology, toxicology

Go to page top
Go back to contents
Go back to site navigation